These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Achieving continence with antimuscarinic therapy for overactive bladder: effects of baseline incontinence severity and bladder diary duration. Wein AJ; Khullar V; Wang JT; Guan Z BJU Int; 2007 Feb; 99(2):360-3. PubMed ID: 17155987 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of tolterodine extended-release in men with overactive bladder and urgency urinary incontinence. Roehrborn CG; Abrams P; Rovner ES; Kaplan SA; Herschorn S; Guan Z BJU Int; 2006 May; 97(5):1003-6. PubMed ID: 16643482 [TBL] [Abstract][Full Text] [Related]
9. Pharmacologic management of urinary incontinence, voiding dysfunction, and overactive bladder. Saks EK; Arya LA Obstet Gynecol Clin North Am; 2009 Sep; 36(3):493-507. PubMed ID: 19932412 [TBL] [Abstract][Full Text] [Related]
10. Persistence with antimuscarinic therapy in patients with overactive bladder. Haab F; Castro-Diaz D Int J Clin Pract; 2005 Aug; 59(8):931-7. PubMed ID: 16033615 [TBL] [Abstract][Full Text] [Related]
11. Cizolirtine citrate is safe and effective for treating urinary incontinence secondary to overactive bladder: a phase 2 proof-of-concept study. Zát'ura F; Vsetica J; Abadías M; Pavlík I; Schraml P; Brod'ák M; Villoria J; Sust M; Eur Urol; 2010 Jan; 57(1):145-52. PubMed ID: 19446951 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis. Wagg A; Wyndaele JJ; Sieber P Am J Geriatr Pharmacother; 2006 Mar; 4(1):14-24. PubMed ID: 16730617 [TBL] [Abstract][Full Text] [Related]
13. Antimuscarinics for the treatment of overactive bladder: current options and emerging therapies. Hegde SS; Mammen M; Jasper JR Curr Opin Investig Drugs; 2004 Jan; 5(1):40-9. PubMed ID: 14983972 [TBL] [Abstract][Full Text] [Related]
14. Antimuscarinic agents: implications and concerns in the management of overactive bladder in the elderly. Kay GG; Granville LJ Clin Ther; 2005 Jan; 27(1):127-38; quiz 139-40. PubMed ID: 15763613 [TBL] [Abstract][Full Text] [Related]
15. Safety and tolerability of tolterodine for the treatment of overactive bladder in adults. Roberts RG; Garely AD; Bavendam T Am J Manag Care; 2005 Jul; 11(4 Suppl):S158-62. PubMed ID: 16161389 [TBL] [Abstract][Full Text] [Related]
16. Pharmacologic management of urinary incontinence in the female. Rovner ES; Wein AJ Minerva Ginecol; 2004 Aug; 56(4):327-47. PubMed ID: 15377982 [TBL] [Abstract][Full Text] [Related]
17. Short- and long-term efficacy of solifenacin treatment in patients with symptoms of mixed urinary incontinence. Staskin DR; Te AE BJU Int; 2006 Jun; 97(6):1256-61. PubMed ID: 16686722 [TBL] [Abstract][Full Text] [Related]
18. [News in the pharmacological treatment of female urinary incontinence]. Martan A Cas Lek Cesk; 2006; 145(7):549-53. PubMed ID: 16921783 [TBL] [Abstract][Full Text] [Related]
20. Urinary incontinence: selected current concepts. Wilson MM Med Clin North Am; 2006 Sep; 90(5):825-36. PubMed ID: 16962844 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]